Investors looking for aerospace and defense exposure often find themselves comparing two distinct approaches: the Themes Transatlantic Defense ETF (NATO) and the State Street SPDR S&P Aerospace & Defense ETF (XAR). Both operate in the same broad sector yet serve different purposes. NATO is a newer, market-cap-weighted vehicle that spans NATO member countries on both sides of the Atlantic, while XAR is a long-established, equal-weight fund focused exclusively on U.S. companies. In the current environment of elevated geopolitical tension and rising European defense commitments, this ETF comparison shows how structural design shapes sector exposure, risk, and relative positioning. I also checked this using Tickeron’s AI Screener to see how the two compare on key metrics.
NATO is a passively managed, non-diversified ETF that seeks to track the Solactive Transatlantic Aerospace and Defense Index. Launched in October 2024, it invests at least 80% of net assets in companies with aerospace and defense operations headquartered in NATO member countries. The fund holds roughly 80–100 securities, weighted by market capitalization, which produces meaningful concentration at the top.
Its largest positions include RTX, Rolls-Royce, GE Aerospace, Boeing, Safran, Airbus, Lockheed Martin, Howmet Aerospace, BAE Systems, and General Dynamics. Industrials represent nearly the entire portfolio, with exposure concentrated overwhelmingly in large-cap names. Geographically, the U.S. accounts for roughly two-thirds of assets, with the United Kingdom, France, the Netherlands, and Germany contributing the balance. The fund charges a 0.35% net expense ratio, but its smaller asset base and lighter trading volume make it structurally less liquid than larger peers.
XAR, launched in September 2011, is a passively managed ETF that tracks the S&P Aerospace & Defense Select Industry Index, a modified equal-weight benchmark representing the aerospace and defense segment of the broader U.S. total stock market. This equal-weight design means no single company dominates the portfolio; each of the roughly 40–50 holdings typically carries a weight in the low single digits.
Representative top holdings include Axon Enterprise, RTX, Lockheed Martin, Northrop Grumman, General Dynamics, HEICO, L3Harris Technologies, Textron, and Huntington Ingalls. The fund is effectively 100% industrials and exclusively U.S.-listed. With a 0.35% net expense ratio, billions in assets under management, and deep daily volume, XAR offers a mature, highly liquid vehicle with over a decade of observable performance history. One thing that stands out here is how its structure reduces single-stock risk compared with more concentrated peers.
Both funds sit at the center of a powerful macro theme: sustained growth in global defense spending. In Europe, NATO members have accelerated rearmament and raised defense budgets in response to shifting security dynamics, a trend that directly benefits European contractors such as Rheinmetall, BAE Systems, Safran, and Airbus. In the United States, demand remains supported by large multi-year procurement programs and replenishment cycles for munitions and advanced systems.
Commercial aerospace also remains a meaningful driver, with aircraft production rates and aftermarket activity influencing suppliers such as Boeing and GE Aerospace. Key sector risks include supply-chain constraints, labor shortages, interest-rate sensitivity for capital-intensive programs, and the political uncertainty surrounding future budget cycles. For fund performance, the distinction matters: NATO captures both U.S. and European spending, while XAR isolates the American defense and aerospace complex. I’m watching this closely because the European spending momentum could continue to influence positioning.
Over recent market cycles, the two funds have diverged in ways that reflect their construction. NATO's market-cap weighting and transatlantic scope give it outsized sensitivity to a handful of mega-cap primes—such as RTX, GE Aerospace, and Boeing—plus direct exposure to the strong European rearmament trend. This concentration can amplify returns when large caps rally but also magnifies drawdowns when a single bellwether disappoints.
XAR's equal-weight approach tilts toward mid-sized suppliers and more evenly distributes risk, which historically tempers volatility tied to any single company's earnings cycle. Its U.S.-only focus means it does not directly capture European defense momentum, but it offers steadier, broader participation across the domestic supply chain. In terms of relative positioning, NATO skews toward large-cap, higher-concentration momentum, while XAR leans toward diversified, lower-concentration consistency—a meaningful trade-off for investors weighing risk tolerance against thematic upside. From what I see, this trade-off is central to deciding between the two.
Tickeron’s AI Screener has become a regular part of my research workflow. It lets me quickly filter ETFs and stocks by technical patterns, fundamentals, trend strength, and volatility, which helps surface differences like concentration levels or liquidity metrics without manual effort. I’ve found it especially useful when comparing vehicles like these two defense funds to refine my shortlist based on objective criteria.
Based on observable structural factors, Tickeron's AI would currently favor XAR over NATO. While NATO offers a compelling, differentiated route into European rearmament, its high top-10 concentration, non-diversified designation, smaller asset base, and lighter trading volume introduce meaningful concentration and liquidity risk. XAR, by contrast, combines an equal-weight design that reduces single-stock exposure, broad diversification across the U.S. aerospace and defense supply chain, deep liquidity, and a lengthy track record at an identical 0.35% cost. In probabilistic terms, XAR's combination of structural strength, cost efficiency, and risk-adjusted positioning gives it the edge for most investors seeking durable sector exposure.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Aroon Indicator for XAR entered a downward trend on November 02, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 124 similar instances where the Aroon Indicator formed such a pattern. In 109 of the 124 cases the stock moved lower. This puts the odds of a downward move at 88%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 57 of 69 cases where XAR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XAR as a result. In 72 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
XAR moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
XAR broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XAR's RSI Oscillator exited the oversold zone, 25 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for XAR just turned positive on October 15, 2026. Looking at past instances where XAR's MACD turned positive, the stock continued to rise in 37 of 42 cases over the following month. The odds of a continued upward trend are 88%.
Following a +1.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where XAR advanced for three days, in 289 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows